Summary.-High-affinity rosette-forming T-cell assays were performed by incubation of peripheral-blood mononuclear cells with sheep erythrocytes (E) at 29°C. As compared with normal controls, the levels of high-affinity rosette-forming cells (RFC) were much more frequently depressed in cancer patients than were the total E-RFC incubated at 4°C. Only 2/83 normal controls had less than 38% 29°C E-RFC (mean 48 ± 5), whilst 78/89 cancer patients were below this level. The few postoperative patients tested exhibited a normal range of 29°C E-RFC.
HUMAN thymus-derived lymphocytes, or T cells, have been shown to be the principal effectors of cellular immunity. Estimates of circulating T cells, as measured by rosette formation with sheep erythrocytes, (SRBC), suggest that changes in the percentage of rosetteforming cells (E-RFC) may be a reliable index of the level of immuno-competence of the host. However, there are a number of conflicting reports on the proportion of E-RFC in cancer patients. Some authors (Stjernsward et al., 1972; Nemoto et al., 1974) have reported a normal proportion of T cells in breast-cancer patients, while others described depressed E-RFC in similar patients (Keller et al., 1976; Whitehead et al., 1976; Moroz et al., 1977; Whitehead et al., 1978) and in other malignant diseases (Catalona et al., 1974; Gross et al., 1975) .
Other studies have suggested that modification of the rosette technique with suboptimal rosetting conditions apparently permitted better discrimination between normal individuals and cancer patients. Therefore, procedures for detecting a subpopulation of the total E-RFC, termed "active" T-RFC, have been described (Wybran & Fudenberg, 1973; Smith et al., 1975) . Wybran & Fudenberg (1973) found that T lymphocytesforming "active" rosettes were diminished in patients with various neoplasms, whereas the total number of T cells was frequently normal in such patients. Recently, West et al. (1976) and Weese et al. (1977) have found that, with the suboptimal temperature 2900, a "highaffinity" rosette-forming T-cell assay (2900 E-RFC) was useful in distinguishing between normal individuals and those with cancer and certain other diseases.
The present study was carried out to evaluate the proportion of "high-affinity" E-RFC and 40C E-RFC in the peripheral blood of cancer patients. Lymphocyte separation.-Ten to 25 ml of heparinized (20 i.u./ml) blood were diluted with Eagle's minimum essential medium (MEM) to 50 ml. The diluted blood was centrifuged on a layer of Ficoll-Triosil (density 1-078) for 15 min at 20°C with 900 g at the interface. The layers rich in mononuclear cell were harvested, pooled and centrifuged at 500 g for 10 min at 20°C. The lymphocytes were then washed twice with MEM and the final pellet was resuspended at 5 X 106/ml in RPMI 1640 medium (Eurobio) supplemented with 2 mm glutamine (Grand Island Biological Co., Grand Island, N.Y.), penicillin (100 u/ml) and streptomycin (100,ug/ml ' West et al. (1976) . Briefly, 0-1 ml of lymphocytes (5 x 106/ml) was mixed well with 0-1 ml of AB serum and 041 ml of SRBC (0-5%o) at a a final SRBC: PBL ratio of 40: 1. Tubes were incubated at 37TC for 5 min, centrifuged at 200 g for 5 min and the resulting pellet was incubated at 4TC overnight.
High-affinity or 29°C E-RFC.-This differed from the total E-RFC assay mainly in that the overnight incubation at 4TC was replaced by incubation at 29TC in a waterbath for 1 h.
E-rosette-forming lymphocytes were quantified in both assays after gentle resuspension of the cell pellets: one from of the suspension was placed on a haemacytometer and the number ofrosettes (3 or more SRBC surrounding a lymphocyte) was counted. All tests were performed in duplicate and at least 200 lymphocvtes were counted each time.
RESULTS

40C E-RFC
As shown in Fig. 1 , the mean percentage of 4°C E-RFC in the 83 normal subjects was 65 + 6 (mean i s.d.). The lower limit of normal has therefore been defined as the mean 2 s.d., or 5300. Two normal subjects had E-RFC level lower than this. Thirty-five patients with nonmalignant diseases exhibited a mean 4°C E-RFC level of 63 i 9; only one of them, afflicted with alcoholic cirrhosis, had a level lower than 53% (190/ In this study we have found that there is no significant difference with our technique in 4°C E-RFC values between normal subjects and cancer patients. We showed that only 9/89 cancer patients (10%) had a level of 4°C E-RFC below the lower normal limit (53%) defined as the mean value 2 s.d. The high level of tofal E-RFC in cancer patients in our studies may be due to the overnight incubation as demonstrated by Whitehead et al. (1978) ; however, with our ratio of-SRBC to lymphocytes (40:1), there is no effect of incubation time at 4°C on rosette formation, according to Chisholm et at. (1976) . It is reported that the depressed response to phytohaemagglutinin and in the MLC of blood lymphocytes in some cancer patients is due to the presence of suppressor cells, even though the total E-RFC is within the normal range (Berlinger et al., 1976; Zembala et al., 1977; Quan & Burtin, 1978) . Thus the level of 4°C E-RFC does not always correlate well with the clinical and immune status of patients with malignant diseases. Other studies have suggested that a modification of the rosette technique will allow measurement of a T-cell subpopulation, and that a large proportion of cancer patients can be identified by abnormally low levels of this T subpopulation. Wybran & Fudenberg (1973) , using the "active" rosette assay, have demonstrated a decrease in rosette formation by PBL of cancer patients, whereas the majority of these patients had a normal percentage of total E-RFC.
More recently, on the basis of relative affinity for SRBC, West et al. (1976) have reported a 29°C rosette assay (with a ratio SPBC/PBL at 120/1) as useful in distinguishing between normal individuals and those with cancer and certain other diseases.
Using the same method, but with a ratio of SRBC/PBL 40/1, we have demonstrated that patients with malignancies have an abnormally low level of the subpopulation of T cells which forms rosettes at elevated temperatures. Our findings confirmed those of West et al. (1976) and Jerells et al. (1978) . Most cancer patients show a level of highaffinity E-RFC below the lower limit of normal values (38%).
In patients with non-cancerous diseases, there were 7 with a high-affinity RFC level below 38%. Of these 7, 4 were at an advanced stage of alcoholic cirrhosis with markedly abnormal liver function including raised transaminase levels. Of the 3 other patients, one was suffering from chronic ulcerative colitis, one from Crohn's disease and one from familial colonic polyposis. Low levels of 29WC E-RFC in alcoholic-cirrhosis patients have already been reported (West et al., 1976) . On the other hand, apart from familial colonic polyposis, which is considered as a precancerous condition, it is noteworthy that chronic ulcerative colitis (Kirsner, 1970 ) and Crohn's disease (Perret et al., 1968; Weedon et al., 1973) A change in either of these may result in a change in the percentage of rosette formation (Chisholm & Tubergen, 1976) . At 29TC, there may be a decrease in the density and/or the affinity of SRBC of cancer patients' lymphocyte surface, causing a decline of E-RFC. The way in which the presence of tumour produces the drop in high-affinity rosette-forming cells remains a matter of speculation. It is not known, either, whether the decrease of 290C E-RFC precedes the appearance of the tumour.
We have demonstrated that most cancer patients have a depressed proportion of high-affinity E-RFC in their peripheral blood, contrasting with normal total T-cell levels. According to , the fall of high-affinity E-RFC correlated with an increase in the number of low-affinity E-RFC which possess Fc receptors for IgG and are effector cells in K (West et al., 1978) and NK activity (Kay et al., 1977) . It will, therefore, be important to study concomitantly rosette formation both at 400 and 290C, and cellular immune functions such as K and NK activity in cancer patients. This work was supported by a grant from I.N.S.E.R.M. . The authors thank all the physicians who provided blood specimens, especially Professor Loygue and Dr Hirsch-Marie (H6pital Saint-Antoine, Paris), Professor Fries, Dr
